Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | RXRA | P19793 | 1/20 | 0.47 |
| ▸ | RXRB | P28702 | 1/20 | 0.47 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | TSPO | P30536 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13901065 | 1.00 | GPR3 (0.53) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL17109670 | 1.00 | GPR3 (0.53) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL21031226 | 0.97 | KDM4E (0.52) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL26528387 | 0.97 | KDM4E (0.52) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL18595613 | 0.95 | RXRA (0.53) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL19998687 | 0.95 | KDM4E (0.58) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL19998777 | 0.95 | KDM4E (0.58) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL19101097 | 0.94 | KDM4E (0.56) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL15212965 | 0.93 | KDM4E (0.60) | GPR3KDM4EL3MBTL1MAPTHPGD | |
| SCHEMBL14900743 | 0.93 | KDM4E (0.60) | GPR3KDM4EL3MBTL1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9590190-B2 | Terminally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-03-07 | — | — | US | disclosed |
| US-9590190-B2 | Terminally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-03-07 | — | — | US | disclosed |
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | Shenzhen China Star Optoelectronics Technology Co. Ltd. (CN) | 2015-09-24 | — | — | US | disclosed |
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | Shenzhen China Star Optoelectronics Technology Co. Ltd. (CN) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | OCIAD1, OCIAD2, OGFOD1 | GPR3 1343/4885KDM4E 3472/4885L3MBTL1 1887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.